Essential thrombocythaemia (ET) is a rare myeloproliferative neoplasm characterised by elevated platelet counts, megakaryocyte hyperplasia and enlargement, and one of the following: JAK2, CALR or MPL mutations, a clonal marker, or lack of evidence for reactive thrombocytosis [1, 2]. This evidence concerns the gene MPL and essential thrombocythemia.